Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-2-1
|
pubmed:abstractText |
Platelet activation may limit the response to tissue-type plasminogen activator (t-PA) during coronary thrombolysis in humans. As an index of platelet activation, we assessed thromboxane A2 biosynthesis during coronary thrombolysis with intravenous t-PA in patients with acute myocardial infarction. Urinary 2,3-dinor-thromboxane B2, a metabolite of thromboxane A2, was increased to a peak of 3,327 +/- 511 pg/mg creatinine (n = 12) following administration of intravenous t-PA and remained elevated for 48 hours. This increase was abolished by pretreatment with aspirin 325 mg orally (n = 6), indicating de novo biosynthesis of thromboxane A2 rather than washout of preformed metabolites during reperfusion. Prostacyclin (PGI2) biosynthesis, determined by excretion of 2,3-dinor-6-keto-PGF1 alpha, also increased after t-PA administration. However, this increase was less pronounced in patients who reperfused (28 +/- 3.3 ng.hr/mg creatinine) than in patients who failed to reperfuse (118 +/- 30 ng.hr/mg creatinine, p less than 0.05). These data provide evidence of platelet activation during coronary thrombolysis with t-PA. In patients who reperfuse, the reduction in PGI2 biosynthesis may be a marker of reperfusion injury to the vasculature and may further amplify platelet activation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0009-7322
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1718-25
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2513144-Adult,
pubmed-meshheading:2513144-Aged,
pubmed-meshheading:2513144-Aspirin,
pubmed-meshheading:2513144-Epoprostenol,
pubmed-meshheading:2513144-Female,
pubmed-meshheading:2513144-Humans,
pubmed-meshheading:2513144-Male,
pubmed-meshheading:2513144-Middle Aged,
pubmed-meshheading:2513144-Myocardial Infarction,
pubmed-meshheading:2513144-Myocardial Reperfusion,
pubmed-meshheading:2513144-Platelet Activation,
pubmed-meshheading:2513144-Thrombolytic Therapy,
pubmed-meshheading:2513144-Thromboxane A2,
pubmed-meshheading:2513144-Tissue Plasminogen Activator
|
pubmed:year |
1989
|
pubmed:articleTitle |
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.
|
pubmed:affiliation |
Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee 37232.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|